SM Biochemicals LLC
Catalog #
Peptide Name
Sequence
Size
Price ( $ )
SM641-54
Beta Amyloid (16-10),
reverse, human
Lys-Gln-His-His-Val-Glu-Tyr-OH
1 MG
125
SM641-92
Beta Amyloid (17-40),
human
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-
Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-
Gly-Val-Val-OH
0.5 MG
175
SM641-92
Beta Amyloid (17-40),
human
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Se
r-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-
Gly-Gly-Val-Val-OH
1 MG
245
SM641-92
Beta Amyloid (17-40),
human
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Se
r-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-
Gly-Gly-Val-Val-OH
5 MG
995
SM641-90
Beta Amyloid (17-42),
human
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-
Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-
Gly-Val-Val-Ile-Ala-OH
0.5 MG
195
SM641-90
Beta Amyloid (17-42),
human
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Se
r-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-
Gly-Gly-Val-Val-Ile-Ala-OH
1 MG
255
SM641-90
Beta Amyloid (17-42),
human
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Se
r-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-
Gly-Gly-Val-Val-Ile-Ala-OH
5 MG
995
SM641-44
Beta Amyloid (22-35),
human
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-
Gly-Leu-Met-OH
1 MG
150
SM641-44
Beta Amyloid (22-35),
human
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-I
le-Gly-Leu-Met-OH
5 MG
255
SM640-19
Beta Amyloid (25-35)
[Ala28]
Gly-Ser-Asn-Ala-Gly-Ala-Ile-Ile-Gly-Leu-Met-
OH
1 MG
100
SM640-19
Beta Amyloid (25-35)
[Ala28]
Gly-Ser-Asn-Ala-Gly-Ala-Ile-Ile-Gly-Leu-M
et-OH
5 MG
255
SM640-21
Beta Amyloid (25-35)
[Gly35]
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Gly-
OH
1 MG
100
SM640-21
Beta Amyloid (25-35)
[Gly35]
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-G
ly-OH
5 MG
255
SM641-53
Beta Amyloid (25-35)
[Nle35], human
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle
u-OH
1 MG
150
SM641-41
Beta Amyloid (26-35),
human
Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
1 MG
100
SM641-41
Beta Amyloid (26-35),
human
Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
5 MG
255
SM641-42
Beta Amyloid (27-35),
human
Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
1 MG
100
SM641-42
Beta Amyloid (27-35),
human
Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
5 MG
255
SM641-43
Beta Amyloid (28-35),
human
Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
1 MG
95
SM641-43
Beta Amyloid (28-35),
human
Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
5 MG
245
SM641-29
Beta Amyloid (28-42),
human
Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-V
al-Val-Ile-Ala-OH
0.5 MG
195
SM641-29
Beta Amyloid (28-42),
human
Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-V
al-Val-Ile-Ala-OH
1 MG
245
SM641-47
Beta Amyloid (35-25),
reverse, human
Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-
OH
1 MG
95
SM641-47
Beta Amyloid (35-25),
reverse, human
Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-
OH
5 MG
245
SM641-70
Beta Amyloid (40-1),
reverse, human
Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-G
ly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Ph
e-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-
Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-OH
0.5 MG
245
SM641-70
Beta Amyloid (40-1),
reverse, human
Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-G
ly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Ph
e-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-
Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-OH
1 MG
375
SM641-69
Beta Amyloid (42-1)
reverse, human
Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Il
e-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-
Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-
Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-O
H
0.5 MG
275
SM641-69
Beta Amyloid (42-1)
reverse, human
Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Il
e-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-
Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-
Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-O
H
1 MG
400
SM640-20
Beta Amyloid [Gln 22]
(1-40), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
0.5 MG
275
SM640-20
Beta Amyloid [Gln 22]
(1-40), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
1 MG
400
SM642-30
Beta Amyloid [Gln 22]
(1-42), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-O
H
0.5 MG
275
SM642-30
Beta Amyloid [Gln 22]
(1-42), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-O
H
1 MG
400
SM641-16
Beta Amyloid [Glp3]
(3-42),  human
Glp-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-H
is-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-A
sp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-L
eu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
1 MG
400
SM641-36
Beta Amyloid [Glu11]
(1-16)
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-OH
1 MG
125
SM641-36
Beta Amyloid [Glu11]
(1-16)
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-OH
5 MG
400
SM641-25
Beta Amyloid [Glu11]
(1-38), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-OH
0.5 MG
195
SM641-25
Beta Amyloid [Glu11]
(1-38), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-OH
1 MG
245
SM641-10
Beta Amyloid [Glu11]
(1-40), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
0.5 MG
245
SM641-10
Beta Amyloid [Glu11]
(1-40), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
1 MG
375
SM641-10
Beta Amyloid [Glu11]
(1-40), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Il
e-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
5 MG
1175
SM641-18
Beta Amyloid [Glu11],
(1-28), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH
 
245
SM641-18
Beta Amyloid [Glu11],
(1-28), human
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-G
lu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Al
a-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH
5 MG
775

Supplier of Fluoromethyl Ketones (FMK), Difluorophenoxymethylketone (Q-VD-OPH), Caspase/
Apoptosis  Detection Kits, Calpain Inhibitors, Cathepsin Inhibitors, Antiviral Peptide inhibitor
(Picornavirus 2A Proteinases),  Peptide Aldehyde (CHO), Caspase / Apoptosis Inhibitors and
Substrates, Diazomethylketone Inhibitors, AMC/ AFC/PNA/ Cresyl voilet/ Thiobenzyl Substrates (SBzl),
wide variety of  peptides for both research and bulk pharmeceutical trials. Active Pharmaceutical
Ingredients, Custom Synthesis of Peptide and Organic molecules.

Q-VD-OPH, Z-VD-OPH, Boc-D-OPH, Z-DEVD-OPH, Z-VAD(OMe)-FMK, Z-VAD-FMK( non methylated) Boc-D-
FMK,Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK, Z-VEID-FMK, Z-AEVD-FMK, Z-VDVAD-FMK, Z-LEVD-FMK,Z-
ATAD-FMK, Biotin-VAD-FMK, Biotin-DEVD-FMK, Z-FA-FMK, Biotin-FA-FMK, Z-FF-FMK, Z-LLY-FMK, Z-VAM-
FMK, FITC-VAD-FMK, FAM-VAD-FMK, FAM-DEVD-FMK, SR-VAD-FMK, SR-DEVD-FMK, CASPASE /
APOPTOSIS INHIBITORS AND DETECTION KITS  CATHEPSIN, CALPAIN INHIBITORS, PEPTIDE ALDEHYDE
INHIBITORS,  FLUOROGENIC (AMC, AFC), GLY-PHE-DIAZOMETHYLKETONE,  CHROMOGENIC
( PNA ) SUBSTRATES.

CRESYL VOILET SUBSTRATES ( A new cell  permeable fluorogenic substrate) THIOBENZYL ESTER
(SBzl) SUBSTRATES.

SM Biochemicals offers a wide variety of peptides including Adrenocorticotropic Hormone(ACTH),
Adrenomedullins, ADAM Substrate, Agatoxin IVa, Akt Substrate, All D Beta Amyloid, Alpha MSH, Amylin,
Amyloid, Angiotensin, APP, a great number of Beta Amyloids which have been found to offer useful
tools in Alzheimer's research.Bradykinin, Calcitonin,Casein Kinase, Cecropin B,Cecropin P1,porcine,
Corticotropin,Endothelins, Endothelin Antagonists, Exendin 3,Enzyme Inhibitors, Fibrinogen Binding,
Fibrinopeptide, Flag Peptide,FurinInhibitorII,Galanin,Galantide, Gamma Secretase Inhibitor, Gastric
Inhibitory Peptide, human / GIP, human, Gastrin, Gastrin Releasing Peptide, human / GRP, Ghrelin,
Glucagon,Growth Hormone Releasing Factor, H.I.V. -1 Protease, Hepatitis C Virus, HIV Substrate IV, HIV
Substrate IV Inhibitor I, Humanin, KISS, Leumorphin, LH-RH Free Acid, Locustapyrokinin, MG-132/
Proteosome inhibitor, MMP Substrates and Inhibitors, MOG Protein, Motlin Peptides, Myosin, MZ
Peptides, Neuropeptide, Neurotensin, NFF2 MMP subsrates, Non A Beta component Amyloid, Obestatin,
Oxerin A and Oxerin B ( Human), Orntide, Oxyntomodulin, PACAP, Pancreastatin, Pancreatic
polypeptide, Parathyroid Hormone,PKA Inhibitor and Substrate, Plasminogen activator substrate,
Protein Kinase, PTH Peptide/Protein, PYY Peptide/Protein, Sarafotoxin peptides, Somatostatin peptides,
Syntide, TNF converting enzyme substrate, Tyrosine specific protein kinase, Vasoactive intestinal
constrictor, VIP peptides, VIP Antagonist, VIP Receptor, Xenopsin.


We provide peptides for both research and bulk pharmeceutical trials. A staff with decades of
experience in peptide chemistry will help you with the design and synthesis of your custom peptides
and with the technical information necessary to help you optimize your research results.

Active Pharmaceutical Ingredients ( APIs and Intermediates). Pharmaceutically active peptides

Call our number (714)993-9461 or (925)876-3111 or email at info@smbiochemicals.com
1
5
3
4
2
6
Prev
7
8
Next
9
10
11
12
13
14